New search | Conferencedetail
mail
Print view
 
 

TCR-based Therapies for Solid Tumors Summit

Evvnt Promotion / evvnt
-
03.04.2023 - 05.04.2023  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 09:00 to 16:30
 
Conference themes
The first TCR-based therapy approval in the US and Europe at the start of this year sparked a rush of excitement, investment and collaborations. As further developers move into the clinic and some near commercialization, it's time for this community to unite to address the critical bottlenecks faced in development, from discovery to approval, to guarantee smooth sailing through the clinic.
Scientific Society
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1444012-3?pid=4832

Speakers: Birgit Schultes, Senior Vice President, Cell Therapy, Intellia Therapeutics, Claudia Wagner, Senior Director, Immunology, Head of TCR Discovery and Validation, Immatics, and more
 

Enquiries and Registration:

https://go.evvnt.com/1444012-2?pid=4832
Ms. Ellie Saunders
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5997.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

newTreeCharité International AcademyÖsterreichisches Rotes KreuzHelix - Forschung & Beratung WienAnästhesie in Entwicklungsländern e. V.European Public Health Association (EUPHA)European Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation